Semaglutide is evaluated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition such as type 2 diabetes, prediabetes, high blood pressure, or elevated cholesterol
If you notice these issues, you may need to discontinue usage
Joint and Muscle Repair Supports tendon and ligament healing, reducing downtime from injuries Enhances flexibility and mobility in athletes and active individuals May aid recovery in degenerative conditions like arthritis 3
Remove 99211 and bill 96372 with the J-code only when the visit is solely for the injection
Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi
Start your intake Why GLP-1 Safety Data Remains Limited in Lactation GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) were not studied in breastfeeding populations during clinical development